Today, research is demonstrating that the use of some direct-fed microbials and/or probiotics can have an impact on intestinal (fecal) microbial profiles. Direct-fed microbial supplementation to diets typically results in an increase in the number of Lactobacilli (a beneficial gut bacteria which produces lactic acid) and in the Lactobacilli as a percentage of total anaerobes. The resulting increase in gut lactic acid levels in turn work to reduce the populations of harmful pathogens such as Clostridia, Salmonella, Escherichia coli, and Campylobacter, as shown by intestinal (fecal) microbial profiles, for better gut health and nutrient absorption.

With regards to antibiotics, research studies have shown that they generally act in a different way; by lowering the total microbial counts. Antibiotics not only diminish pathogen levels, but they also reduce counts of some beneficial bacteria such as Lactobacilli.

CALSPORIN® Poultry and Swine producers look to Quality Technology International for CALSPORIN, a direct-fed microbial product containing Bacillus subtilis C-3102 spores, for use as a feed supplement. CALSPORIN may offer solutions to poultry and swine producers when antibiotics and growth promotants (AGP’s) are not an option or when they want to reduce the levels of AGP’s fed in the diet. CALSPORIN therefore, may be a viable feed supplement alternative as it contains spores of a beneficial microorganism and which may improve live and processed animal performance.

CALSPORIN is currently marketed for poultry (meat and egg production) and swine (sows and pigs) in the U.S., Brazil, Japan and other countries in Asia, and after extensive testing, has recently (2006) been approved for broiler chickens in the European Union.

Please call Quality Technology International, or select this e-mail link Calsporin info if you would like additional information on feeding Calsporin.

Calsporin is a registered trademark of Calpis Co., Ltd.